Kristina Burow, Director at Vir Biotechnology, Inc. (VIR), bought 16,555,554 shares at $20.00 ($20.0M) on 2019-10-16, disclosed to the SEC on 2019-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,555,554 | $0 | 0.0% |
| 2 | $20.00 | 1,000,000 | $20.0M | 100.0% |
| Total | $1.21 avg | 16,555,554 | $20.0M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $160K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $40.0M | — | Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |